Literature DB >> 14533659

Elevations of local leukotriene C4 levels during viral upper respiratory tract infections.

Deborah A Gentile1, Philip Fireman, David P Skoner.   

Abstract

BACKGROUND: One potential mechanism by which respiratory viruses trigger illness and complications is via the local elaboration of inflammatory mediators.
OBJECTIVE: To determine whether there is an increase in local leukotriene C4 (LTC4) levels during experimental infection with influenza A virus (FLU), rhinovirus (RV), or respiratory syncytial virus (RSV).
METHODS: Healthy adults were intranasally inoculated with a safety-tested strain of FLU (n = 29), RV (n = 16), or RSV (n = 21). Nasal lavage samples were collected, symptoms were recorded, and expelled nasal secretions were weighed before and then daily after challenge. Lavage samples were submitted for viral culture and assayed for LTC4 levels by radioimmunoassay. Serum antibody titers to the challenge viruses were assayed at baseline and 21 days after challenge.
RESULTS: All subjects were infected as evidenced by viral shedding and/or seroconversion. Following infection, significant increases (P < 0.05 by analysis of variance) in LTC4 levels were measured for each virus. Furthermore, there was a temporal association between the local LTC4 levels and the development of illness.
CONCLUSIONS: The results of this study, which used an adult experimental model, demonstrate elevations in locally produced LTC4 during respiratory infection with FLU, RV, and RSV. Future studies using antileukotriene agents may help elucidate the precise role of leukotrienes in mediating disease expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14533659     DOI: 10.1016/S1081-1206(10)63529-6

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  19 in total

1.  Aryl hydrocarbon receptor targets pathways extrinsic to bone marrow cells to enhance neutrophil recruitment during influenza virus infection.

Authors:  Sabine Teske; Andrea A Bohn; Jason P Hogaboam; B Paige Lawrence
Journal:  Toxicol Sci       Date:  2007-11-15       Impact factor: 4.849

Review 2.  Evolving role of leukotrienes in the pathogenesis of viral infections, including otitis media.

Authors:  Deborah Gentile
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

Review 3.  The role of the respiratory syncytial virus in airway syndromes in childhood.

Authors:  Mark L Everard
Journal:  Curr Allergy Asthma Rep       Date:  2006-03       Impact factor: 4.806

4.  Effects of montelukast on patients with asthma after experimental inoculation with human rhinovirus 16.

Authors:  Kirsten M Kloepfer; Jennifer P DeMore; Rose F Vrtis; Cheri A Swenson; Katie L Gaworski; Jack A Bork; Michael D Evans; James E Gern
Journal:  Ann Allergy Asthma Immunol       Date:  2011-01-13       Impact factor: 6.347

Review 5.  Nasal cytokines as mediators of illness during the common cold.

Authors:  William J Doyle; David P Skoner; Deborah Gentile
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.806

6.  The Tennessee Children's Respiratory Initiative: Objectives, design and recruitment results of a prospective cohort study investigating infant viral respiratory illness and the development of asthma and allergic diseases.

Authors:  Tina V Hartert; Kecia Carroll; Tebeb Gebretsadik; Kimberly Woodward; Patricia Minton
Journal:  Respirology       Date:  2010-03-29       Impact factor: 6.424

Review 7.  Host immune responses to rhinovirus: mechanisms in asthma.

Authors:  John T Kelly; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2008-10       Impact factor: 10.793

Review 8.  Eicosanoids and respiratory viral infection: coordinators of inflammation and potential therapeutic targets.

Authors:  Mary K McCarthy; Jason B Weinberg
Journal:  Mediators Inflamm       Date:  2012-05-15       Impact factor: 4.711

9.  Pilot Study of Peak Plasma Concentration After High-Dose Oral Montelukast in Children With Acute Asthma Exacerbations.

Authors:  Donald H Arnold; Sara L Van Driest; Theodore F Reiss; Jennifer C King; Wendell S Akers
Journal:  J Clin Pharmacol       Date:  2020-09-22       Impact factor: 3.126

10.  Retrospective cohort study of leukotriene receptor antagonist therapy for preventing upper respiratory infection-induced acute asthma exacerbations.

Authors:  Hiroto Matsuse; Tomoko Tsuchida; Susumu Fukahori; Tetsuya Kawano; Shinya Tomari; Nobuko Matsuo; Tomoya Nishino; Chizu Fukushima; Shigeru Kohno
Journal:  Allergy Rhinol (Providence)       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.